How is Rybrevant administered?

Rybrevant is given as an intravenous (IV) infusion into your vein. Your healthcare provider will administer this medication to you, normally in a clinic-like setting. Your doctor will decide the time between doses as well as how many treatments you will receive. It may be given as a single agent or in combination with chemotherapy medicines called carboplatin and pemetrexed.

Patients usually receive this medicine until their cancer worsens or they have side effects that require the drug to be stopped. Your doctor will determine your dose (based on your weight), how many treatments you will receive, and how often you receive them.

Infusion reactions are common with Rybrevant. You will receive medicines before each dose (called "premedications") to help reduce your risk of an infusion-related reaction.

Symptoms of the infusion-related reaction may include:

• shortness of breath
• flushing
• fever
• chills
• nausea
• chest discomfort
• low blood pressure
• vomiting.

Tell your doctor right away if you have any of these side effects. Your doctor may need to temporarily stop your infusion, decrease your dose or completely stop your treatment with Rybrevant if you have serious side effects.

What is Rybrevant used for?

Rybrevant (amivantamab-vmjw) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread in the body or cannot be removed by surgery.

• Patients who receive Rybrevant have certain abnormal epidermal growth factor receptor “EGFR” genes and their NSCLC has worsened while on or after chemotherapy that contains platinum.
• Your doctor can perform a blood test to make sure you can receive Rybrevant.
• For some patients, it may be used in combination with carboplatin and pemetrexed, 2 chemotherapy medicines.

Related: Rybrevant side effects (in more detail)

Related Questions

• How do Exkivity and Rybrevant compare for NSCLC?
• How does Rybrevant work?
• Is small cell or non-small cell lung cancer worse?

Can it be administered at home?

Rybrevant is not normally given at your home. You would typically receive this medicine in a healthcare facility or clinic with appropriate personnel, medicine and equipment so you can be monitored and treated for any infusion-related reactions. Your doctor will tell you when and where you will receive your infusion.

If you miss your appointment, call your healthcare provider as soon as possible to reschedule.

This is not all the information you need to know about Rybrevant (amivantamab-vmjw) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Rybrevant information here, and discuss this information and any questions you have with your doctor or other health care provider.